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1. Introduction 
Rickettsia prowazekii and R. rickettsii are HHS and USDA select agents 
(http://biosafety.utk.edu/pdfs/salist.pdf), and R. prowazekii is a category B bioterrorism 
agent as determined by the Centers for Disease Control and Prevention (CDC) 
(http://www.bt.cdc.gov/agent/agentlist-category.asp). The criteria for CDC category B 
bioterrorism agents are that the organisms are moderately easy to disseminate, cause 
diseases with moderate morbidity and low mortality and require specific enhancements of 
diagnostic capacity and enhanced disease surveillance. However, the case fatality ratios of 
both R. prowazekii and R. rickettsii may exceed the CDC bioterrorism agent category B level. 
Epidemic typhus caused by R. prowazekii and Rocky Mountain spotted fever (RMSF) caused 
by R. rickettsii can reach up to 60% fatalities without antibiotic treatment and 4% even with 
antibiotic treatment (Raoult et al., 2004). Rickettsia had been explored for biowarfare use.  
The former Soviet Union developed R. prowazekii as a biologic weapon in the 1930s (Alibek 
K and Handelman S, 2009). During World War II, the Japanese performed human 
experiments with rickettsial agents for purposes of biologic weapon development during 
their occupation of China (Harris S, 1992).  
Epidemic typhus, also known as louse-borne typhus, has been distributed worldwide, 
was one of the man’s major scourges and frequently played a decisive role in wars in 
Europe from the 15th through 20th centuries, thus affecting the course of European history 
(Conlon JM, 2007). It killed millions of people through this period. Although worldwide 
epidemics of typhus may not occur again, the threat of louse-borne typhus is still real as 
small scale epidemics or large scale epidemics in settings of extreme poverty and natural 
and manmade disasters. Louse-borne typhus occurs in epidemics when social, economic, 
or political systems are disrupted exposing a large population such as refugees to louse 
infestation due to lack of hygiene. This situation has been observed in recent outbreaks of 
typhus in Burundi, Algeria, Peru, and Russia. In 1997, it was estimated that as many as 
100,000 cases of typhus occurred in the refugee camps of Burundi during a civil war 
(Raoult et al., 2004).  
RMSF originated as an emerging infectious disease on the western frontier in the Rocky 
Mountains. Now the disease is found all over the United States, and over half of the cases 
occur in the southeastern and south-central regions of the United States and in South 
America (Center for Disease Control and prevention[CDC], 2010).  
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2. Etiologic agents  
Rickettsia are small (0.3 – 0.5 x 0.8 – 1.0 µm) gram-negative obligately intracellular bacterial 
parasites of eukaryotic cells. The genus is subdivided into the typhus group (TG) and 
spotted fever group (SFG) based on lipopolysaccharide (LPS) antigens. The TG rickettsiae 
include louse-borne R. prowazekii that causes epidemic typhus and flea-borne R. typhi that 
causes murine typhus. The SFG rickettsiae consist of more than 20 named species, which are 
transmitted by tick bite except for R. akari (mite-borne) and R. felis (flea-borne). Antibodies 
to LPS antigens cross-react among organisms within the same biogroup, but do not cross-
react between the two groups (Vishwanath, 1991). There are two major outer membrane 
proteins in Rickettsia OmpA (Sca 0) and OmpB (Sca5). OmpB exists in all Rickettsia and 
OmpA exists only in SFG rickettsiae. Genomic sequencing identified additional 14 surface 
cell antigens (Scas) among Rickettsia (Blanc et al., 2005). However, most sca genes are 
degenerated in Rickettsia, and only two Scas (Sca4 and Sca5 also called OmpB) present in all 
Rickettsia. Scas of gram-negative bacteria belong to the autotransporter protein family which 
are usually associated with virulence functions.  
2.1 Pathogenesis and pathophysiology 
In vitro experiments showed that Rickettsia attaches to the host cell through its surface 
proteins, OmpB, OmpA, Sca1, and Sca2, and host cell receptors (Martinez et al., 2005). 
After attachment, Rickettsia induces non-phagocytic endothelial cells to engulf it. Once it 
enters the host cell, Rickettsia immediately lyses the phagosomal membrane and escapes 
into the cytoplasm. Rickettsia multiplies by binary fission with a doubling time of 8 hours. 
Both TG and SFG rickettsiae multiply in the cytoplasm of host cells, but SFG rickettsiae 
can also invade and multiply in the nucleus of host cells. TG rickettsiae accumulate in 
cytoplasm until the host cell bursts, but SFG rickettsiae seldom accumulate in host cells. 
The difference in the quantity of organisms that accumulate in host cells between TG and 
SFG rickettsiae is believed to be caused by the facts that SFG rickettsiae move by actin-
based mobility inside the cytoplasm and can spread to adjacent cells, but TG rickettsiae do 
not move and cannot spread. SFG rickettsiae hijack the cell's actin which they stimulate to 
polymerize at one bacterial pole to facilitate their own movement (Teysseire et al., 1992). 
Due to the actin-based movement, SFG rickettsiae spread from cell to cell eventuating in 
cell death and thus the formation of large plaques in cell culture. In contrast, typhus 
group rickettsiae accumulate in the host cell and form very small plaques when the 
heavily infected cells burst.  
The target cell of Rickettsia in vivo is microvascular endothelium. The crucial 
pathophysiologic effect of rickettsial endothelial infection is increased microvascular 
permeability resulting from discontinuities in interendothelial adherens junctions. The 
pathogenic mechanisms of endothelial injury include endothelial cell production of toxic 
reactive oxygen species, damage to the cell membrane upon rickettsial exit, and cytotoxic T 
lymphocyte-induced apoptosis of infected endothelial cells. Rickettsial infections cause a 
procoagulant state, but only very rarely disseminated intravascular coagulation. Thrombi 
comprise non-occlusive hemostatic plugs that are appropriately located at foci of severe 
endothelial damage to mitigate hemorrhage (Walker DH, 2011). 
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2.2 Epidemiology and ecology 
A part or the entire life cycle of rickettsiae is usually associated with one species of 
arthropod, including lice, fleas, ticks and mites. Arthropods are the vectors and, in most 
cases, the reservoir of rickettsiae. The distribution of tick-borne SFG rickettsioses are 
restricted to areas where their tick reservoirs are present, such as Rocky Mountain spotted 
fever in the Americas, Mediterranean spotted fever in Europe, Africa and Asia, and 
Japanese spotted fever in Japan and eastern Asia (Table 1). Human louse-, flea-, and mouse 
 
Disease Rickettsial agent Vector Geographic Distribution 
SFG rickettsiae 
African tick- bite fever Rickettsia africae Ticks Sub-Saharan Africa, Caribbean 
islands (Mediannikov et al., 2010) 
Far eastern spotted fever Rickettsia 
heilongjiangensis 
Ticks Far East of Asia (Mediannikov et 
al., 2004) 
Flinders Island spotted 
fever 
Rickettsia honei Ticks Australia and southeastern Asia 
(Graves S & Stenos J, 2003) 
Mediterranean spotted 
fever 
Rickettsia conorii Ticks Southern Europe, southern and 
western Asia, and Africa (Rovery et 
al., 2008) 
North Asian tick typhus 
Lymphangitis-associated 
rickettsiosis 
Rickettisa sibirica 
Rickettsia sibirica 
mongolotimonae 
Ticks Asia, Europe, and Africa (Fournier 
et al., 2005) 
Japanese spotted fever Rickettsia japonica Ticks Japan and eastern Asia (Chung et 
al., 2006) 
Queensland tick typhus Rickettsia australis Ticks Australia (Sexton et al., 1991) 
Rocky Mountain spotted 
fever 
Rickettsia rickettsii Ticks North, Central and South America 
(Galvao MA et al., 2003) 
Tick-borne 
lymphadenopathy 
Rickettsia slovaca Ticks Europe (Selmi et al., 2008) 
Unnamed Rickettsia parkeri Ticks North and South America (Nava et 
al., 2008) 
Unnamed Rickettsia massiliae Ticks Europe and North and South 
America (Labruna MB, 2009) 
Unnamed Rickettsia 
aeschlimannii 
Ticks Europe and Africa (Raoult et al., 
2002) 
Unnamed Rickettsia 
monacensis 
Ticks Europe (Jado et al., 2007) 
Unnamed Rickettsia helvetica Ticks Europe and Asia (Fournier et al., 
2004) 
Rickettsialpox R. akari Mite Worldwide 
Cat flea rickettsiosis R. felis Flea Worldwide 
TG rickettsiae 
Epidemic typhus R. prowazekii Louse Worldwide 
Murine typhus R. typhi Flea Worldwide 
Table 1. Distribution of rickettsioses 
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mite-borne Rickettsia such as R. prowazekii, R. typhi, R. felis, and R. akari are distributed 
worldwide with their hosts and vectors.  
Non-virulent or low virulence SFG rickettsiae may be maintained in nature largely via 
transovarian transmission in the arthropod hosts. However, highly virulent SFG rickettsiae 
such as R. rickettsii and R. conorii are pathogenic for the Dermacentor and Rhipicephalus ticks, 
respectively (Niebylski et al., 1999; Santos et al., 2002). Virulent rickettsiae such as R. 
rickettsii need an animal host to amplify the organisms for establishing new lines of 
transovarian rickettsial maintenance (e.g., D. variabilis ticks acquire R. rickettsii while feeding 
on rickettsemic cotton rats) (Niebylski et al., 1999). Each species of pathogenic SFG 
rickettsiae may have one or multiple tick vector species. The vectors of Rocky Mountain 
spotted fever are D. variabilis (American dog tick) in the eastern two-thirds of the US and 
regions of the Pacific coast states, D. andersoni (wood tick) in the Rocky Mountain states, 
Rhipicephalus sanguineus (brown dog tick) in the southwestern US, northern Mexico, and 
South America and Amblyomma cajennense and A. aureolatum in South America. The seasonal 
and geographic distribution of each rickettsiosis reflects the months of activity of the vector 
and its contact with humans. Over 90% of cases with Rocky Mountain spotted fever occur 
during April through September. Approximately 250-2000 cases of Rocky Mountain spotted 
fever have been reported annually in the United States (CDC, 2010).   
Epidemic typhus is transmitted primarily by the human body louse, Pediculus humanus 
corporis. However, the louse is only a vector and not a reservoir because infected lice die 5-7 
days after they become infected with R. prowazekii. Rickettsia prowazekii multiplies in louse 
gut epithelium, which detaches, ruptures and releases rickettsiae into the feces. The louse 
feces containing rickettsiae are scratched into the skin, rubbed into mucous membranes such 
as the conjunctiva, or inhaled. Humans can develop latent infection after acute louse-borne 
typhus and serve as reservoirs of R. prowazekii. R. prowazekii can be reactivated causing 
recrudescent typhus fever (Brill-Zinsser disease) when latently infected persons’ immunity 
wanes.  Rickettsia prowazekii is also maintained in a zoonotic cycle involving flying squirrels 
(Glaucomys volans) and their specific flea and louse in the United States. Sporadic epidemic 
typhus occurring in the United States is transmitted by fleas of flying squirrels (Duma et al., 
1981). Murine typhus is transmitted by fleas including rat fleas and cat fleas. 
3. Virulence determinants of Rickettsia 
Rickettsia has no exotoxin, and rickettsial LPS is not toxic and apparently is not associated 
with the pathogenesis of Rickettsia infections. Since Rickettsia are obligately intracellular 
bacteria, their survival mechanisms involve proteins related to the attachment, to entry into 
and exit from host cells, and enzymes for protein and DNA modification and obtaining 
nutrition from the host.    
Adhesins: The first step for obligately intracellular Rickettsia to establish infection is to adhere 
to and invade the host endothelium. These processes require the interaction of rickettsial 
surface proteins with mammalian host cell receptors. Three outer membrane proteins of 
Rickettsia OmpA, OmpB, and Sca2 have been identified as adhesins of Rickettsia(Li & 
Walker, 1998; Martinez et al., 2005; Cardwell & Martinez, 2009). OmpB has been 
demonstrated to interact with its mammalian receptor, Ku70. However, in Ku70–/– mouse 
embryonic fibroblasts R. conorii invasion is reduced only 50 to 60%, suggesting that Rickettsia 
may use multiple adhesins and receptors.  
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Membranolytic enzymes: Internalized rickettsiae are initially bound within a phagosome 
(Teysseire et al., 1995). Rickettsia quickly (<10 min) lyse the phagosomal membrane to escape 
from phagosomal vacuoles before phagolysosomal fusion occurs, which would result in the 
death of the Rickettsia through the activity of the lysosomal enzymes (Teysseire et al., 
1995;Hackstadt, 1996;Feng & Walker, 2000;Walker et al., 2001a). Rickettsia are also required 
to exit the host cell by lysis of the host cell membrane. The mechanism of lysis of the 
phagosomal membrane and the host cell membrane has been hypothesized to be mediated 
by a phospholipase enzyme (Radulovic et al., 1999;Renesto et al., 2003). The genomic 
sequences of Rickettsia have revealed four proteins with potential membranolytic activities: 
patatin B1 precursor (pat-1 gene), hemolysin A (tlyA), hemolysin C (tlyC), and 
phospholipase D (pld) (Andersson et al., 1998;Ogata et al., 2001;McLeod et al., 2004). TlyC 
has been demonstrated to have hemolytic activity, (Radulovic et al., 1999) and can mediate 
escape by S. enterica serovar Typhimurium from phagosomes (Whitworth et al., 2005). 
Patatin B of R. typhi (RT0522) has been implicated as a phospholipase A2. However, 
knockout of R. prowazekii pld gene does not prevent R. prowazekii escape from the phagosome 
or exit from host cells. Patatin B is truncated by an ISRpe 1 transposon in R. peacockii, which 
apparently does not affect the release of R. peacockii from phagosomes (Felsheim RF). These 
observations suggest that the multiple membranolytic enzymes of Rickettsia may be 
functionally redundant.  
Actin-based mobility: Like other intracytosolic bacteria such as Listeria monocytogenes and 
Shigella flexneri, SFG rickettsiae exploit the host cell actin cytoskeleton to promote 
intracellular mobility and cell-to-cell spread by assembling distinctive 'comet tails' that 
consist of long, unbranched actin filaments(Tilney and Portnoy, 1989;Bernardini et al., 
1989;Teysseire et al., 1992;Heinzen et al., 1993). The molecular mechanisms of actin 
polymerization by L. monocytogenes and S. flexneri primarily involve activation of the Arp2/3 
complex, an actin nucleator that can initiate the polymerization of new actin filaments and 
organize filaments into Y-branched arrays (Mullins et al., 1998;Welch et al., 1998;Blanchoin 
et al., 2000). In host cells, the Arp2/3 complex is activated by nucleation-promoting factors 
including members of the Wiskott–Aldrich syndrome protein (WASP) family of 
proteins(Higgs & Pollard, 2001;Welch & Mullins, 2002). The mechanisms of activation of the 
Arp2/3 complex by intracellular pathogens are that they express surface proteins that 
recruit host WASP family proteins (e.g., S. flexneri IcsA), or they express functional mimics 
of WASPs (e.g., L. monocytogenes ActA) (Goldberg, 2001). It was proposed that actin in 
Rickettsia comet tails is nucleated by the host Arp2/3 complex, and the bacterial protein 
RickA has been shown to assemble branched actin networks in vitro(Jeng et al., 2004;Gouin 
et al., 2004) . Coincidently, RickA is inactivated by an ISRpe1 transposon in R. peacockii, 
which does not have actin-based mobility(Simser et al., 2005). However, a new discovery 
suggests that besides RickA Sca2 is also involved in the actin-based mobility of Rickettsia. 
Knocking out the sca2 gene completely aborts actin-based mobility of R. rickettsii. Sca2 
mimics eukaryotic formins to determine the unique organization of actin filaments in 
Rickettsia tails and to drive bacterial mobility, independently of host nucleators. Actin-based 
mobility is important for the virulence of some rickettsiae such as R. rickettsii, but it is not 
important for the virulence of TG rickettsiae because TG rickettsiae do not have actin-based 
mobility or have only erratic mobility. Even SFG rickettsiae with actin-based mobility are 
not all virulent such as R. bellii, a tick symbiont, which has actin-based mobility but has not 
yet been shown to cause disease in humans or animals.  
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Methyltransferase: The patterns of methylation of lysine in the surface antigens of avirulent 
Madrid E (E) strain, virulent revertant Evir strain, and wild type Breinl strain of R. prowazekii 
are different. The major surface antigen of the virulent Breinl and Evir strains contains more 
Nє-Me3-lysine and less Nє-Me-lysine than the avirulent E strain (Rodionov et al., 1991;Turco 
& Winkler, 1994). Outer membrane protein B (OmpB) is heavily methylated in the virulent 
strains, while OmpB from the attenuated strain is hypomethylated(Ching et al., 1992). The 
methyltransferase gene (Rp028/Rp027) is inactivated by a frameshift mutation in E strain, 
but the mutation reverts to wild type in the virulent revertant Evir strain. A single 
nucleotide mutation in the methyltransferase gene is the only mutation in E strain compared 
to Evir strain (Yu, unpublished data). Taken together our results and the previous discovery 
that E strain is deficient in methylation of OmpB suggests strongly that the reversible 
mutation in the methyltransferase gene determines the virulence state of E strain, i.e., the 
organisms become avirulent when the gene is inactivated in E strain, and the organisms 
become virulent when the gene function is restored in Evir strain.  
3.1 Clinical spectrum/treatment 
Spotted fever: Rocky Mountain spotted fever caused by R. rickettsii is a very severe disease, 
and fatal cases occur in association with delayed or ineffective antibiotic treatment in as 
many as 4% of cases. RMSF occurs 1 -2 weeks after feeding by an infected tick. The disease is 
characterized by acute onset of fever that may be accompanied by headache, malaise, 
myalgia, nausea/vomiting, or neurologic signs. A macular or maculopapular rash appears 
3-5 days following onset in most (~90%) patients, and the rash has a centripetal pattern of 
spread, meaning that it begins on the extremities and spreads towards the trunk. In severe 
disease, petechiae appear in the center of the maculopapules. However, 10% to 15% of 
persons with RMSF never develop a rash, a condition referred to as "Rocky Mountain 
spotless fever"(Sexton & Corey, 1992). The target of Rickettsia is endothelium of blood vessels. 
Inflammation and damage of endothelia of capillary blood vessels by Rickettsia results in 
increased vacular permeability, which causes rash, hypovolemic hypotension, pulmonary 
and cerebral edema and organ failure.   
Other spotted fevers may have similar clinical symptoms as RMSF, but are less severe. Rash 
is less frequent in less severe rickettsioses such as African tick bite fever and R. parkeri 
infection. Focal skin necrosis with a dark scab (an eschar) at the site of tick feeding is a 
common feature of boutonneuse fever, African tick bite fever, North Asian tick typhus, 
Queensland tick typhus, Japanese spotted fever, Flinders Island spotted fever, rickettsialpox, 
tick-borne lymphadenopathy, and the recently described infections in the US caused by R. 
parkeri and a novel strain 364 D, but is rare in Rocky Mountain spotted fever.  
Typhus: Epidemic typhus and murine typhus are caused by R. prowazekii and R. typhi, 
respectively. Historically murine typhus and epidemic typhus were difficult to differentiate 
due to similar clinical symptoms, but epidemic typhus is more severe than murine typhus. 
Murine typhus occurs predominantly in summer and fall, and epidemic typhus usually 
occurs in winter. Symptoms of typhus may include high fever (105 - 106 degrees 
Fahrenheit), which may last up to 2 weeks, severe headache, severe muscle pain (myalgia), 
dry cough, delirium, stupor, and a dull red rash that begins on the trunk and spreads 
peripherally.  
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Tetracyclines are first-line treatment, and doxycycline may be used to avoid tooth staining 
in children. Tetracyclines are rickettsiostatic, not rickettsicidal. Chloramphenicol is a second 
line, less effective treatment that can be used in the rare instance of contraindication to use 
of doxycycline. Ciprofloxacin, other fluoroquinolones, azithromycin, and clarinthromycin 
are effective against certain rickettsiae but are not recommended for the severe rickettsioses. 
Because diagnostic tests can take time and may be insensitive, antibiotics are usually begun 
presumptively to prevent significant deterioration, complications, death, sequelae, and 
prolonged recovery.  
3.2 Immune mechanisms of Rickettsia 
Most of our understanding of the immune response against Rickettsia is derived from in vitro 
studies as well as the murine models of rickettsioses. Proinflammatory cytokines such as 
IFN-γ and TNF-α are essential for primary defense against rickettsial infection. These 
cytokines act in concert to activate endothelial cells, the major target cells of rickettsial 
infections, as well as other minor target cells to kill intracellular organisms via nitric oxide 
synthesis-dependent and indoleamine 2,3-dioxygenase-dependent mechanisms. The sources 
of these protective cytokines are hypothesized to be the T lymphocytes and macrophages 
that infiltrate the perivascular space surrounding the vessels with infected endothelium.  
Cell mediated immunity plays a critical role in host defenses against rickettsial 
infections(Walker et al., 2001b). There are two important effector components of the 
acquired immune response against Rickettsia, namely IFN- γ production by CD4+ and CD8+ 
type-1 cells, which activates intracellular bactericidal mechanisms of endothelial cells and 
macrophages, and the generation of Rickettsia-specific cytotoxic CD8+ T cells that induce 
apoptosis in infected target cells via pathways involving perforin and/or granzymes. CD8+ 
T cells are more important in clearance of rickettsial infection than CD4+ T cells(Walker et 
al., 2001b). Although adoptive transfer of either CD4 or CD8 immune T lymphocytes 
controls the infection and leads to survival, only depletion of CD8 T lymphocytes alters the 
outcome of infection, and depletion of CD4 cells has no observed effect on the course or 
outcome of infection(Walker et al., 2001c).  
The humoral response may play an important role in protection against infection, and 
antibodies against surface protein antigens are very likely critical effectors of vaccine–
associated protective immunity. In animal experiments, antibodies to Rickettsia or rickettsial 
outer membrane proteins can neutralize rickettsia (Anacker et al., 1987;Li et al., 1988). 
However, natural infection does not result in the production of protective antibodies prior 
to clearance of rickettsiae. Thus, humoral immunity may be more important in preventing 
reinfection and in vaccine-induced immunity than in clearance of primary infection.  
4. Experimental vaccines and other potential vaccine prospects 
Currently no commercial vaccine is available for any rickettsial disease. Infection with R. 
rickettsii and R. conorii is believed to confer long lasting immunity against re-infection. Thus, 
it is feasible to develop a vaccine against rickettsial diseases. In theory, a subunit vaccine 
targeting a conserved rickettsial protein such as OmpB may be developed to prevent all 
rickettsial diseases. An attenuated organism that can multiply, but does not cause disease in 
the host, has been proved to be effective in protection against rickettsial infections in 
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humans and laboratory animals. Attenuated Rickettsia has been selected by passage in 
chicken egg yolk sacs in the past and was recently achieved by gene knockout technology.  
Inactivated vaccine. The history of development of vaccines against rickettsial diseases 
contains numerous failures and limited success in preventing or ameliorating disease. Killed 
rickettsial vaccine was prepared from infected ticks in 1924, in yolk sac of embryonated 
chicken eggs in 1938 (Cox HR, 1939), and from cell culture in the 1970s (Gonder et al., 
1979;Kenyon et al., 1979). The original tick-derived rickettsial vaccine produced severe local 
inoculation site reactions(Spencer RR and Parker RR, 1925). Evaluation of its protective 
effect in field use was impressive by the standards of the day. The fatality rate from Rocky 
Mountain spotted fever among vaccine recipients was reduced dramatically although illness 
and even death occurred in some vaccinated persons. The killed yolk sac-derived rickettsial 
vaccine was never field tested. When tested by challenge of human volunteers, neither the 
yolk sac vaccine nor the tick vaccine prevented the illness, which, of course, was treated to 
prevent severe illness or death. The yolk sac vaccine was withdrawn from the market in 
1978. A subsequent challenge trial of a cell culture killed-R. rickettsii vaccine yielded 
protection of 25% of the volunteers who received it(Gonder et al., 1979).    
Subunit vaccine for Rickettsia. Two surface protein antigens of R. rickettsii, OmpA and OmpB, 
have been identified as major protective antigens and are candidates for use as subunit 
vaccines. The first evidence that OmpA and OmpB contain protective epitopes came from 
the studies of monoclonal antibodies to heat sensitive epitopes of OmpA and OmpB, which 
neutralized R. rickettsii toxicity in mice and infection in guinea pigs (Anacker et al., 1987;Li 
et al., 1988). The E. coli-expressed OmpA N-terminal fragment partially protects guinea pigs 
against a lethal challenge dose of R. rickettsii (McDonald et al., 1988). A fragment from the 
N-terminus of R. conorii OmpA protects guinea pigs against experimental infection with R. 
conorii and partially protects guinea pigs from challenge with the heterologous R. rickettsii 
(Vishwanath et al., 1990). Fragments of the ompA and ompB genes have been tested as DNA 
vaccines. In a regimen of DNA immunization followed by boosters of the corresponding 
peptide, mice immunized with R. rickettsii ompA or ompB fragments are partially protected 
against a lethal challenge with heterologous R. conorii(Diaz-Montero et al., 2001). It is not 
known whether the incomplete protection of OmpA and OmpB against the heterologous 
Rickettsia species challenge in these experiments is caused by the antigenic differences 
between the rickettsial species, the immunization regimen, or the antigen composition. 
Live vaccine. The attenuated Madrid E (E) strain of R. prowazekii was used in humans as an 
experimental vaccine from the 1950s to 1970s. E strain is a spontaneous laboratory variant of 
R. prowazekii that was isolated from a typhus patient in Madrid in 1941 and passed in rapid 
succession in embryonated chicken eggs 255 times. This strain has limited virulence for 
guinea pigs and low virulence for humans. E strain is protective and provides long term 
immunity against louse-borne typhus. Ninety-four percent (170/181) of immunized persons 
were protected from natural infection by epidemic typhus compared to the unvaccinated 
controls in a 14-month period after vaccination. Ninety-six percent (27/28) of volunteers 
who were vaccinated with E strain and subsequently challenged with Breinl strain at 
intervals from 2 months to 36 months remained healthy following challenge, and 83% (5/6) 
of the volunteers who were challenged at 48 to 66 months were protected(FOX et al., 1961). 
However, the E strain vaccine caused a late reaction in up to 14% of vaccinated persons 9-14 
days after inoculation. The late reaction varied from simple malaise and mild headache to 
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modified typhus characterized by fever, headache, malaise and occasionally a rash in a 
small proportion of subjects. The reason for the late reaction was not known at the time. In 
1970s a virulent revertant Evir strain was isolated from guinea pigs by passage of E strain in 
guinea pigs or mice.  
Attenuation of Rickettsia by gene knockout. Because of the difficulty of transforming Rickettsia, 
scientists were unable to knock out rickettsial genes to determine their function and to create 
an attenuated rickettsial vaccine until recently. The phopholipase D (pld) gene was the first 
rickettsial gene that was genetically knocked out. The pld-inactivated Evir strain is avirulent 
for guinea pigs at doses for which the Evir strain is virulent and stimulates protective 
immunity to virulent R. prowazekii (Driskell et al., 2009). Genetic inactivation of sca-2 in R. 
rickettsii results in loss of actin-based mobility in cell culture (Kleba et al., 2010). Sca-2 
deficient R. rickettsii lacks the ability to cause disease in guinea pigs, but stimulates 
protection against challenge with virulent R. rickettsii (Kleba et al., 2010). Thus, Sca-2 and 
phospholipase D-deficient strains should be further evaluated as vaccines for Rocky 
Mountain spotted fever and epidemic typhus. Genetically attenuated Rickettsia are the 
strongest future prospect for developing an effective rickettsial vaccine. 
Differentiation of strains of R. prowazekii and R. rickettsii. R. prowazekii has been isolated 
from humans, flying squirrels, and ticks for more than half century. Due to different sources 
and different passages, R. prowazekii strain can be grouped in to three virulence groups: high 
virulence group represented by Breinl strain, medium virulence group represented by flying 
squirrel isolates and low virulence or non-virulence group represented by Madrid E strain 
and its revertant strains. All strains of R. prowazekii can be differentiated by sequencing 
several loci of the genome of R. prowazekii (Zhu et al., 2008). R. rickettsii strains were not 
genetically typed except for virulent R strain and nonvirulent Iowa strains, whose whole 
genomes were completely sequenced (Ellison et al., 2008).  
5. Conclusion 
There has been progress in molecular biology, cellular biology and immunology and 
pathogenesis of Rickettsia. However, diagnosis of rickettsial diseases is still difficult and is 
usually retrospective. Rapid diagnostic methods are required for diagnosis of rickettsial 
diseases and in response to bioterrorism.  
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